Smith & Nephew plc (LON:SN) has received an average recommendation of “Hold” from the fourteen ratings firms that are presently covering the firm. Nine investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is GBX 1,306.17 ($15.88).

Several brokerages have recently commented on SN. Jefferies Group reduced their price objective on shares of Smith & Nephew plc from GBX 1,395 ($16.96) to GBX 1,370 ($16.66) and set a “buy” rating for the company in a research report on Wednesday, December 7th. J P Morgan Chase & Co reaffirmed a “neutral” rating and set a GBX 1,260 ($15.32) price objective on shares of Smith & Nephew plc in a research report on Wednesday, January 4th. Deutsche Bank AG reaffirmed a “hold” rating on shares of Smith & Nephew plc in a research report on Wednesday, October 26th. Credit Suisse Group reaffirmed a “neutral” rating and set a GBX 1,285 ($15.63) price objective on shares of Smith & Nephew plc in a research report on Monday, October 31st. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Smith & Nephew plc in a research report on Wednesday.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this report on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The legal version of this report can be accessed at http://www.dailypolitical.com/2017/01/14/smith-nephew-plc-sn-given-average-rating-of-hold-by-analysts.html.

Smith & Nephew plc (LON:SN) opened at 1236.00 on Monday. Smith & Nephew plc has a one year low of GBX 1,040.36 and a one year high of GBX 1,324.00. The firm’s market capitalization is GBX 11.05 billion. The company’s 50-day moving average is GBX 1,158.89 and its 200-day moving average is GBX 1,212.62.

About Smith & Nephew plc

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives.

Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.